Pegzilarginase: Accelerated Approval For Arginase 1 Deficiency (ARG1-D) Hyperargininemia

This episode is 2 minutes long.

This episode was published on April 3, 2026.

Pegzilarginase, first disease-modifying therapy for Arginase 1 deficiency, lowers toxic arginine levels, slows neurological damage, and transforms care through enzyme replacement, accelerated approval, and multidisciplinary support.

Yes, you can download this episode by clicking the download button on the episode player, or subscribe to the podcast in your preferred podcast app for automatic downloads.